Addex Therapeutics Statistics

Total Valuation

ADXN has a market cap or net worth of $7.73 million. The enterprise value is $5.06 million.

Market Cap	7.73M
Enterprise Value	5.06M

Important Dates

The last earnings date was Thursday, December 4, 2025, before market open.

Earnings Date	Dec 4, 2025
Ex-Dividend Date	n/a

Share Statistics

ADXN has 116.57 million shares outstanding. The number of shares has increased by 7.75% in one year.

Current Share Class	n/a
Shares Outstanding	116.57M
Shares Change (YoY)	+7.75%
Shares Change (QoQ)	+12.09%
Owned by Insiders (%)	17.78%
Owned by Institutions (%)	2.15%
Float	88.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	38.88
Forward PS	n/a
PB Ratio	1.03
P/TBV Ratio	1.03
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	25.45
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.01, with a Debt / Equity ratio of 0.01.

Current Ratio	2.01
Quick Ratio	1.91
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-741.34

Financial Efficiency

Return on equity (ROE) is -72.84% and return on invested capital (ROIC) is -18.13%.

Return on Equity (ROE)	-72.84%
Return on Assets (ROA)	-15.90%
Return on Invested Capital (ROIC)	-18.13%
Return on Capital Employed (ROCE)	-40.30%
Revenue Per Employee	$99,412
Profits Per Employee	-$3.82M
Employee Count	2
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +7.92% in the last 52 weeks. The beta is 2.10, so ADXN's price volatility has been higher than the market average.

Beta (5Y)	2.10
52-Week Price Change	+7.92%
50-Day Moving Average	8.87
200-Day Moving Average	8.29
Relative Strength Index (RSI)	44.11
Average Volume (20 Days)	8,067

Short Selling Information

Short Interest	4,316
Short Previous Month	9,545
Short % of Shares Out	0.41%
Short % of Float	n/a
Short Ratio (days to cover)	0.23

Income Statement

In the last 12 months, ADXN had revenue of $198,824 and -$7.65 million in losses. Loss per share was -$0.07.

Revenue	198,824
Gross Profit	-659,225
Operating Income	-3.11M
Pretax Income	-7.77M
Net Income	-7.65M
EBITDA	-3.08M
EBIT	-3.11M
Loss Per Share	-$0.07

Full Income Statement

Balance Sheet

The company has $2.74 million in cash and $45,836 in debt, giving a net cash position of $2.70 million or $0.02 per share.

Cash & Cash Equivalents	2.74M
Total Debt	45,836
Net Cash	2.70M
Net Cash Per Share	$0.02
Equity (Book Value)	7.47M
Book Value Per Share	0.06
Working Capital	1.49M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-1.98M
Capital Expenditures	n/a
Free Cash Flow	-1.96M
FCF Per Share	-$0.02

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,564.90%
Pretax Margin	-3,909.99%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ADXN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.75%
Shareholder Yield	-7.75%
Earnings Yield	-98.91%
FCF Yield	-25.34%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 23, 2023. It was a reverse split with a ratio of 1:20.

Last Split Date	Oct 23, 2023
Split Type	Reverse
Split Ratio	1:20

Scores

ADXN has an Altman Z-Score of -66.7 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-66.7
Piotroski F-Score	1